The University of Insubria is an Italian university located in Como and Varese, with secondary locations in Busto Arsizio and Saronno. It was founded in 1998, it has been named after the area where it is situated, the historical-geographical region of Insubria.

During the past decade, University of Insubria conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Insubria" #1 sponsor was "Università degli Studi dell'Insubria" with 10 trials, followed by "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 2 trials sponsored, "Xeltis" with 2 trials sponsored, "C. R. Bard" with 1 trials sponsored and "European Society of Anaesthesiology" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Insubria" #1 collaborator was "European Society of Anaesthesiology" with 3 trials as a collaborator, "Università degli Studi dell'Insubria" with 2 trials as a collaborator, "Alfa Wassermann, Bologna, Italy" with 1 trials as a collaborator, "Asklepios Kliniken Hamburg GmbH" with 1 trials as a collaborator and "Cedars-Sinai Medical Center" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "University of Insubria" are "Venous Thromboembolism" (5 trials), "Postoperative Respiratory Complications" (2 trials), "Acute Respiratory Failure, Adult" (1 trials), "Arteriovenous Fistula" (1 trials) and "Blood Clot" (1 trials). Many other conditions were trialed in "University of Insubria" in a lesser frequency.

Most popular intervention types in "University of Insubria" are "Drug" (8 trials), "Device" (4 trials), "Procedure" (3 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Aqualief" (1 trials), "Covid-19 vaccine" (1 trials), "Direct Oral Anticoagulants" (1 trials) and "Endometrial biopsy with the hysteroscopic alligator grasper" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Insubria" are 21 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "University of Insubria". 1 are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in University of Insubria, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of Insubria, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 10 trials that are defined as “Not Applicable".